MusclePharm Analysis
MusclePharm's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. MusclePharm's financial risk is the risk to MusclePharm stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that MusclePharm's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which MusclePharm is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of MusclePharm to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, MusclePharm is said to be less leveraged. If creditors hold a majority of MusclePharm's assets, the Company is said to be highly leveraged.
MusclePharm is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of MusclePharm pink sheet analysis is to determine its intrinsic value, which is an estimate of what MusclePharm is worth, separate from its market price. There are two main types of MusclePharm's stock analysis: fundamental analysis and technical analysis.
The MusclePharm pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
MusclePharm |
MusclePharm Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. The quote for MusclePharm is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MusclePharm contact Ryan Drexler at 800 859 3010 or learn more at https://www.musclepharm.com.MusclePharm Investment Alerts
| MusclePharm is not yet fully synchronised with the market data | |
| MusclePharm has some characteristics of a very speculative penny stock | |
| MusclePharm has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 50.04 M. Net Loss for the year was (12.87 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MusclePharm generates negative cash flow from operations |
MusclePharm Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the MusclePharm's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of MusclePharm, which in turn will lower the firm's financial flexibility.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding MusclePharm to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in MusclePharm Pink Sheet
If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |